Abstract

The intestinal anaerobic bacterium Akkermansia muciniphila is specialized in the degradation of mucins, which are heavily O-glycosylated proteins that constitute the major components of the mucus lining the intestine. Despite that adhesion to mucins is considered critical for the persistence of A. muciniphila in the human intestinal tract, our knowledge of how this intestinal symbiont recognizes and binds to mucins is still limited. Here, we first show that the mucin-binding properties of A. muciniphila are independent of environmental oxygen concentrations and not abolished by pasteurization. We then dissected the mucin-binding properties of pasteurized A. muciniphila by use of a recently developed cell-based mucin array that enables display of the tandem repeats of human mucins with distinct O-glycan patterns and structures. We found that A. muciniphila recognizes the unsialylated LacNAc (Galβ1-4GlcNAcβ1-R) disaccharide selectively on core2 and core3 O-glycans. This disaccharide epitope is abundantly found on human colonic mucins capped by sialic acids, and we demonstrated that endogenous A. muciniphila neuraminidase activity can uncover the epitope and promote binding. In summary, our study provides insights into the mucin-binding properties important for colonization of a key mucin-foraging bacterium.

Intestinal mucus consists of densely O-glycosylated mucins, serving as a nutrient source for bacteria. Elzinga et al. show that mucin-degrading Akkermansia muciniphila selectively binds to O-glycan structures found on human colonic mucins.

Details

Title
Binding of Akkermansia muciniphila to mucin is O-glycan specific
Author
Elzinga, Janneke 1   VIAFID ORCID Logo  ; Narimatsu, Yoshiki 2   VIAFID ORCID Logo  ; de Haan, Noortje 3   VIAFID ORCID Logo  ; Clausen, Henrik 4   VIAFID ORCID Logo  ; de Vos, Willem M. 5   VIAFID ORCID Logo  ; Tytgat, Hanne L. P. 6   VIAFID ORCID Logo 

 Wageningen University & Research, Laboratory of Microbiology, Wageningen, The Netherlands (GRID:grid.4818.5) (ISNI:0000 0001 0791 5666); Faculty of Health Sciences, University of Copenhagen, Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X) 
 Faculty of Health Sciences, University of Copenhagen, Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X); GlycoDisplay ApS, Copenhagen, Denmark (GRID:grid.510946.f) 
 Faculty of Health Sciences, University of Copenhagen, Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X); Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000 0000 8945 2978) 
 Faculty of Health Sciences, University of Copenhagen, Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X) 
 Wageningen University & Research, Laboratory of Microbiology, Wageningen, The Netherlands (GRID:grid.4818.5) (ISNI:0000 0001 0791 5666); Faculty of Medicine, University of Helsinki, Human Microbiome Research Program, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071) 
 Wageningen University & Research, Laboratory of Microbiology, Wageningen, The Netherlands (GRID:grid.4818.5) (ISNI:0000 0001 0791 5666); Nestlé Research, Nestlé Institute of Health Sciences, Lausanne, Switzerland (GRID:grid.419905.0) (ISNI:0000 0001 0066 4948) 
Pages
4582
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3061544523
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.